Skip to content
  • Home
  • About IPPI
    • Our Purpose
    • Team & Affiliates
    • Advisory Board
    • Funding & Support
    • Institutional Partners
    • History
  • Blog
    • IPPI Blog
    • List of All Blog Posts
  • Writing
    • Amicus Briefs
    • Letters, Comments, & Testimony
    • Policy Writing
    • Scholarship
  • Events
    • All Events
    • Conflicts Calendar
    • IPPI 2026 Winter Institute
      • 2026 Agenda
    • WIPO-U.S. Summer School on IP
      • 2026 Draft Agenda
  • Edison Fellowship
  • Contact
IPPI: The IP Policy Institute

IPPI: The IP Policy Institute

The University of Akron School of Law

[Archived Post] A Cure Worse Than the Disease? Proposed Changes to European Patent Law are Threatening Pharmaceutical Innovation

Posted on: November 16, 2018May 13, 2026Innovation , Patent Law , Pharma

Innovation is all around us. We love and appreciate the latest video games, software apps, and smartphones. We await the integration of self-driving cars and other forms of artificial intelligence. […]

[Archived Post] Innovate4Health: Embrace Infant Warmers Help Save Lives of Preterm Babies in Developing Countries

Posted on: December 7, 2017May 13, 2026Innovate4Health

This post is one of a series in the #Innovate4Health policy research initiative. By Gleb Savich Preterm birth is the leading cause of death for children under five years old. […]

[Archived Post] CPIP & ITIF Launch “Innovate4Health” Policy Research Initiative

Posted on: April 26, 2017May 13, 2026Innovate4Health , Innovation

In celebration of World Intellectual Property Day on April 26, 2017, the Center for the Protection of Intellectual Property (CPIP) today joined with the Information Technology and Innovation Foundation (ITIF) […]

[Archived Post] Innovate4Health: mPedigree Battles Counterfeit Drugs Through Innovative Verification System

Posted on: March 17, 2017May 13, 2026Innovate4Health

This post is one of a series in the #Innovate4Health policy research initiative. By Kevin Madigan Counterfeit medicines sold under a product name without proper authorization are a serious threat […]

Recent Posts

  • Domestic Manufacturing as a Discretionary Consideration: Domestic Industry at the PTAB?
  • If AI Can Pirate the Internet, Why Can’t You?
  • Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs
  • IPPI 2026 Spring Progress Report
  • IPPI 2025 Winter Progress Report

Archives

Theme Alaska Blog by Kantipur Themes